Current Valuation
N/A
As of December 1, 2024
Total Funding Raised
$16.5M
Last Round
Later Stage VC

Amount undisclosed

Last Funding
Dec 2024

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Apitbio is currently valued at N/A as of December 1, 2024. The company has raised a total of $16.5M in funding.

Investment Perspective

Apitbio's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track Apitbio Valuation Updates

Get notified when Apitbio raises new funding or valuation changes

What is Apitbio Worth in 2025?

As of 2025, Apitbio is valued at N/A, based on the company's Later Stage VC funding round in December 1, 2024. This valuation positions Apitbio as one of the leading private companies in the sector.

Apitbio Valuation History

Apitbio's funding history demonstrates steady growth and investor confidence.

How Apitbio Valuation is Determined

Private company valuations like Apitbio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

Apitbio Valuation FAQs

Is Apitbio profitable?

Apitbio has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does Apitbio's valuation compare to competitors?

Apitbio is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will Apitbio IPO?

Apitbio has not announced plans for an initial public offering. Until an IPO, investors can access Apitbio shares through secondary market platforms.